Genix Pharmaceuticals Corporation
GENPF
$0.01
-$0.02-53.00%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -158.95% | -1.33% | 42.18% | -72.77% | 104.06% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.60% |
| Total Amortization of Deferred Charges | -75.00% | -- | -- | -- | 0.00% |
| Total Other Non-Cash Items | 125.05% | 28.33% | -13.64% | 194.74% | -106.33% |
| Change in Net Operating Assets | -89.66% | 736.36% | 230.95% | -566.67% | 77.10% |
| Cash from Operations | 24.32% | 65.97% | 76.80% | -40.95% | 33.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -97.36% | -65.67% | -73.76% | 36.32% | -33.86% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 65.25% | -65.59% | -75.06% | 29.53% | -39.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,022.22% | -60.00% | 300.00% | -241.18% | -83.33% |